Decreased absolute counts of circulating CD4+ T cell subsets were observed in patients with RA and circulating Tregs which mediate immune tolerance, may be involved in the pathogenesis of RA. Tregs can be restored by low-dose IL2 therapy without obvious side effects and effectively induce remission in RA patients. The gene discussed is CD4; the disease is rheumatoid arthritis.